CN101967188B - 一种人凝血因子ⅷ的制备工艺 - Google Patents
一种人凝血因子ⅷ的制备工艺 Download PDFInfo
- Publication number
- CN101967188B CN101967188B CN2010105348499A CN201010534849A CN101967188B CN 101967188 B CN101967188 B CN 101967188B CN 2010105348499 A CN2010105348499 A CN 2010105348499A CN 201010534849 A CN201010534849 A CN 201010534849A CN 101967188 B CN101967188 B CN 101967188B
- Authority
- CN
- China
- Prior art keywords
- chromatography column
- hours
- minute
- cryoprecipitate
- adds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004519 manufacturing process Methods 0.000 title abstract description 10
- 229960002661 human antihemophilic factor Drugs 0.000 title abstract 2
- 238000004587 chromatography analysis Methods 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 20
- 238000005406 washing Methods 0.000 claims abstract description 15
- 239000007788 liquid Substances 0.000 claims abstract description 14
- 241000700605 Viruses Species 0.000 claims abstract description 8
- 230000008929 regeneration Effects 0.000 claims abstract description 8
- 238000011069 regeneration method Methods 0.000 claims abstract description 8
- 230000002779 inactivation Effects 0.000 claims abstract description 7
- 238000003916 acid precipitation Methods 0.000 claims abstract description 6
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 6
- 238000004108 freeze drying Methods 0.000 claims abstract description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 28
- 238000002360 preparation method Methods 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 239000011780 sodium chloride Substances 0.000 claims description 14
- 238000002347 injection Methods 0.000 claims description 12
- 239000007924 injection Substances 0.000 claims description 12
- 239000011259 mixed solution Substances 0.000 claims description 12
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 108010039209 Blood Coagulation Factors Proteins 0.000 claims description 9
- 102000015081 Blood Coagulation Factors Human genes 0.000 claims description 9
- 239000003114 blood coagulation factor Substances 0.000 claims description 9
- 229940019700 blood coagulation factors Drugs 0.000 claims description 9
- 238000005516 engineering process Methods 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 9
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 6
- 229910052782 aluminium Inorganic materials 0.000 claims description 6
- 239000004411 aluminium Substances 0.000 claims description 6
- 239000001110 calcium chloride Substances 0.000 claims description 6
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 6
- 230000009849 deactivation Effects 0.000 claims description 6
- 239000003292 glue Substances 0.000 claims description 6
- 235000013905 glycine and its sodium salt Nutrition 0.000 claims description 6
- 229920000669 heparin Polymers 0.000 claims description 6
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 claims description 6
- 229960001008 heparin sodium Drugs 0.000 claims description 6
- 239000001509 sodium citrate Substances 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims description 6
- 229940038773 trisodium citrate Drugs 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 230000008021 deposition Effects 0.000 claims description 4
- 210000002381 plasma Anatomy 0.000 claims description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 4
- 229920000053 polysorbate 80 Polymers 0.000 claims description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- STCOOQWBFONSKY-UHFFFAOYSA-N tributyl phosphate Chemical compound CCCCOP(=O)(OCCCC)OCCCC STCOOQWBFONSKY-UHFFFAOYSA-N 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 239000003480 eluent Substances 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 238000004094 preconcentration Methods 0.000 claims description 2
- 238000010792 warming Methods 0.000 claims description 2
- 239000008215 water for injection Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 2
- 239000012535 impurity Substances 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 abstract 2
- 238000003672 processing method Methods 0.000 abstract 2
- 238000001179 sorption measurement Methods 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 235000013861 fat-free Nutrition 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000005342 ion exchange Methods 0.000 abstract 1
- 238000002844 melting Methods 0.000 abstract 1
- 230000008018 melting Effects 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 208000009292 Hemophilia A Diseases 0.000 description 2
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000010836 blood and blood product Substances 0.000 description 2
- 229940125691 blood product Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 102100026735 Coagulation factor VIII Human genes 0.000 description 1
- 201000003542 Factor VIII deficiency Diseases 0.000 description 1
- 208000031220 Hemophilia Diseases 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 238000010327 methods by industry Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105348499A CN101967188B (zh) | 2010-11-08 | 2010-11-08 | 一种人凝血因子ⅷ的制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105348499A CN101967188B (zh) | 2010-11-08 | 2010-11-08 | 一种人凝血因子ⅷ的制备工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101967188A CN101967188A (zh) | 2011-02-09 |
CN101967188B true CN101967188B (zh) | 2012-11-28 |
Family
ID=43546421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010105348499A Active CN101967188B (zh) | 2010-11-08 | 2010-11-08 | 一种人凝血因子ⅷ的制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101967188B (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102228683B (zh) * | 2011-06-21 | 2013-03-13 | 南岳生物制药有限公司 | 冻干人凝血因子ⅷ的制备方法 |
CN102430116A (zh) * | 2011-08-19 | 2012-05-02 | 上海新兴医药股份有限公司 | 用于人凝血因子ⅷ制剂的干热处理方法及其稳定剂 |
CN102924562B (zh) * | 2012-11-19 | 2014-07-23 | 成都蓉生药业有限责任公司 | 一种人凝血因子ⅷ的干热处理稳定剂及其用途 |
CN104250299A (zh) * | 2013-06-25 | 2014-12-31 | 上海生物制品研究所有限责任公司 | 一种人凝血因子ⅷ的制备方法 |
CN103864919A (zh) * | 2014-02-08 | 2014-06-18 | 新疆德源生物工程有限公司 | 一种用于分离纯化凝血因子ⅷ的方法 |
CN103864920B (zh) * | 2014-02-08 | 2016-04-13 | 新疆德源生物工程有限公司 | 一种从血浆中提取人凝血因子ⅷ的工艺 |
CN103848886B (zh) * | 2014-03-28 | 2015-09-09 | 成都蓉生药业有限责任公司 | 一种冷沉淀的制备方法以及用其制备凝血因子ⅷ制剂的方法 |
CN104225601B (zh) * | 2014-09-25 | 2017-11-14 | 广东双林生物制药有限公司 | 人凝血因子viii冻干及干热处理保护剂 |
CN104231073B (zh) * | 2014-09-25 | 2017-01-25 | 广东双林生物制药有限公司 | 一种人凝血因子viii的制备方法 |
CN105524894B (zh) * | 2016-02-26 | 2019-03-26 | 福建华灿制药有限公司 | 凝血因子xiii的制备方法 |
CN107226859B (zh) * | 2017-08-10 | 2020-11-24 | 博雅生物制药集团股份有限公司 | 一种人凝血因子ⅷ的制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5410022A (en) * | 1992-04-24 | 1995-04-25 | Immuno Aktiengesellschaft | Method of producing a factor VIII preparation |
-
2010
- 2010-11-08 CN CN2010105348499A patent/CN101967188B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5410022A (en) * | 1992-04-24 | 1995-04-25 | Immuno Aktiengesellschaft | Method of producing a factor VIII preparation |
Non-Patent Citations (1)
Title |
---|
T Burnouf et al.A Highly Purified Factor VIII:c Concentrate Prepared from Cryoprecipitate by Ion-Exchange Chromatography.《Vox Sang》.1991,第60卷8-15. * |
Also Published As
Publication number | Publication date |
---|---|
CN101967188A (zh) | 2011-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101967188B (zh) | 一种人凝血因子ⅷ的制备工艺 | |
CN101974070B (zh) | 一种人凝血酶原复合物的制备工艺 | |
CN107226859B (zh) | 一种人凝血因子ⅷ的制备方法 | |
CN102228683B (zh) | 冻干人凝血因子ⅷ的制备方法 | |
CN104231072B (zh) | 一种从冷沉淀提取凝血因子ⅷ的废料中提取人纤维蛋白原的制备工艺 | |
CN104231073B (zh) | 一种人凝血因子viii的制备方法 | |
CN102532304B (zh) | 人血白蛋白的制备方法 | |
CN104328101B (zh) | 一种凝血酶的制备方法 | |
CN113563457B (zh) | 一种同时制备人纤维蛋白原、凝血因子ⅷ和纤溶酶原的方法 | |
CN102127165B (zh) | 一种从血浆组分四沉淀中制备高纯ApoA-I的生产工艺 | |
CN104371982A (zh) | 一种慢病毒的纯化方法 | |
CN105175486A (zh) | 一种高纯人凝血因子ix的制备方法 | |
CN110257358B (zh) | 一种高纯人凝血因子ix制剂的生产方法 | |
CN106676089B (zh) | 一种从血浆中制备人凝血酶原复合物的方法 | |
CN104225601B (zh) | 人凝血因子viii冻干及干热处理保护剂 | |
CN105294858A (zh) | 一种冻干人凝血因子viii的制备方法 | |
CN111378029B (zh) | 一种人凝血因子ix的制备方法 | |
CN105250226B (zh) | 一种猪凝血酶冻干粉的制备方法 | |
CN107365376A (zh) | 一种鹿血清蛋白的提取方法 | |
CN102584611B (zh) | 一种药用级缬氨酸的生产方法 | |
CN105440127B (zh) | 一种以人血浆Cohn组分III为原料的FEIBA的制备方法 | |
CN108441490B (zh) | 一种流动吸附法制备人凝血酶原复合物的工艺 | |
CN103893135B (zh) | 一种人血浆蛋白c的冻干稳定剂组合物及其用途 | |
CN102146134B (zh) | 一种高效提取纯化凝血因子ix和凝血因子x的方法 | |
Haanen et al. | Preparation and clinical use of factor IX concentrate PPSB according to Soulier |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Liang Xiaoming Inventor after: Ai Wen Inventor after: He Shuqin Inventor after: Liao Cuanxi Inventor after: Rao Zhen Inventor after: Deng Zhihua Inventor before: Liang Xiaoming Inventor before: He Shuqin Inventor before: Liao Cuanxi Inventor before: Yao Zhen Inventor before: Deng Zhihua |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIANG XIAOMING HE SHUQIN LIAO XINXI YAO ZHEN DENG ZHIHUA TO: LIANG XIAOMING AI WEN HE SHUQIN LIAO XINXI RAO ZHEN DENG ZHIHUA |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 344000 Jiangxi city of Fuzhou province high tech Industrial Park Hui Road No. 333 Patentee after: Boya biopharmaceutical group Limited by Share Ltd Address before: 344000 No. 161 Gan Dong Avenue, Fuzhou, Jiangxi Patentee before: Jiangxi Boya Bio-Pharmaceutical Co., Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 344000 No. 333, Huiquan Road, Fuzhou high tech Industrial Development Zone, Fuzhou City, Jiangxi Province Patentee after: China Resources Boya biopharmaceutical Group Co.,Ltd. Address before: 344000 No. 333 Huiquan Road, Fuzhou High-tech Industrial Park, Jiangxi Province Patentee before: BOYA BIO-PHARMACEUTICAL GROUP CO.,LTD. |